World-Class Cancer Care, Now Within Reach
Precision radiotherapy, Sino-Australian cooperation, and internationally trained oncology experts — together at one modern center in Guangzhou, China.
15+
Oncology Sub-specialties
39+
Oncology Specialists
5
Precision Platforms
7
Patient Languages
A Modern Sino-Australian Cooperative Cancer Center
The Oncology Medical Center of Jinshazhou Hospital of Guangzhou University of Chinese Medicine is built to the standards of China's Grade-A tertiary cancer specialist hospitals and top-tier international medical institutions.
Through long-term cooperation with Australia's ICON Group, international experts regularly join clinical consultations, bringing world-class oncology care within reach.
The hospital is a large public tertiary (Class-III) general hospital integrating medical care, teaching, research and prevention, located at No. 1 Lichuandong Street, Baiyun District, Guangzhou. It operates 1,500 beds, 48 intensive care beds and 31 laminar-flow operating rooms (including 5 Class-100 and 8 interventional rooms), with a planned Phase-III expansion adding 500 VIP wards and a 60,000 m² building.
The Jinshazhou Advantage
Built to international standards with Sino-Australian cooperation, bringing world-class oncology care within reach.
MDT Model
Multi-disciplinary teams of oncology experts design personalized treatment plans for every patient.
Precision Equipment
CyberKnife M6, TomoTherapy and TrueBeam/Halcyon/Ethos platforms for precise, image-guided radiotherapy.
International Network
Sino-Australian cooperation and visiting international experts for global-standard care.
Transparent Care
Open clinical data and real patient reviews make medical decisions credible.
Five World-Class Clinical Platforms
Internationally leading equipment supports five major platforms for precision cancer care.
Medical Imaging
20+ imaging systems with fusion imaging, enabling multi-modal biological target delineation for precise radiotherapy.
Nuclear Medicine
Class-4 radiopharmaceutical license, cyclotron, PET/MRI with Compass, 2 PET-CT and SPECT/CT; nuclide therapies including Y-90, I-131 and Sr-89.
Tumor Radiotherapy
International-standard radiotherapy systems with a complete quality-control and information-management framework.
Comprehensive Treatment
Da Vinci surgical robot, DSA hybrid operating room, cryoablation, HIFU, photodynamic and deep hyperthermia systems.
Precision Diagnostics
2,600+ inspection items; the laboratory meets ISO 15189 and US CAP quality standards.
Precision Radiation Therapy
Five advanced platforms for image-guided, adaptive and high-precision cancer treatment.
Accuray CyberKnife M6
Robotic radiosurgery with real-time tumor tracking for head, spine and lung lesions.
TomoTherapy System
Helical intensity-modulated radiation therapy (IMRT) with integrated imaging.
Varian TrueBeam
High-speed image-guided linear accelerator for fast, precise treatment.
Varian Halcyon / Ethos
Ring-based platform with adaptive radiation therapy (ART).
Siemens CT Simulator
High-definition CT simulation for accurate treatment planning.
HDR / LDR Brachytherapy
Precise internal radiation for gynecologic and other localized tumors.
First-in-China and Clinical Milestones
- China's first Accuray M6 CyberKnife with multi-leaf collimator and dynamic tracking — installed 2019.
- China's first Halcyon v4.0 with HyperSight image guidance — upgraded September 15, 2025.
- Ethos — the world's first AI-based online adaptive radiotherapy system — in clinical use since 2023.
- MR-based synthetic CT and 4D MRI self-gating simulation in clinical use since 2025.
Nuclear Medicine Diagnosis & Treatment
Comprehensive radionuclide imaging and therapy with GMP-standard radiopharmacy and an on-site cyclotron.
I-131 for Thyroid Cancer
One of the earliest targeted therapies and theranostics; a key step of the surgery + I-131 + TSH suppression pathway.
Y-90 SIRT for Liver Tumors
Selective internal radiation therapy for unresectable liver tumors, including colorectal liver metastases and primary liver cancer.
I-131 for Hyperthyroidism
Simple, effective with low recurrence and few side effects; suitable for enlarged thyroids and patients intolerant to antithyroid drugs.
Sr-89 for Bone Metastases
Long-lasting pain relief for bone metastases from prostate, breast and lung cancer.
P-32 Patch Therapy
Simple, safe and effective treatment for keloids and infantile hemangiomas.
Specialist Teams
More than 39 specialists across 15+ oncology sub-specialties, organized into four clinical teams.
Radiation Oncology
Radiotherapy, radiosurgery and medical physics support.
Medical Oncology
Chemotherapy, targeted therapy, immunotherapy and systemic care.
Interventional Oncology
Minimally invasive image-guided interventional procedures.
Surgical Oncology
Robotic and minimally invasive surgical oncology.
Latest Updates
CyberKnife M6 in Clinical Use
Real-time tumor tracking radiosurgery is now available for international patients.
Sino-Australian Expert Consultations
Visiting Australian specialists hold regular joint consultations with our MDT.
International Patient Support
Multilingual care coordinators assist patients in 7 languages from first contact to follow-up.
Clinical Outcomes
Selected anonymized cases from our precision radiotherapy center.
Brain Glioma · Age 10
CyberKnife M6, 25 Gy in 5 sessions — follow-up at 2 months showed tumor reduction, with speech and limb function restored.
Nasopharyngeal Cancer · Age 66
VMAT 69.96 Gy in 33 fractions — the tumor disappeared and positive lymph nodes shrank significantly at follow-up.
Cervical Cancer · Stage IIIB · Age 53
Definitive radiotherapy (external beam + brachytherapy) — the large tumor completely disappeared.
Frequently Asked Questions
Do you accept international patients?
How do I book a consultation?
Can I get a treatment plan before traveling?
Do you provide translation support?
How do I reach the hospital?
Contact Us
Tell us about your case — we reply within 24 hours.